Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Q2 2022 Amedisys Inc Earnings Call Transcript

Jul 28, 2022 / 03:00PM GMT
Release Date Price: €123 (-0.81%)
Operator

Greetings. Welcome to Amedisys Second Quarter 2022 Earnings Call. (Operator Instructions) Please note this conference is being recorded.

At this time, I'll turn the conference over to Nick Muscato with Investor Relations. Nick, you may now begin.

Nick Muscato
Amedisys, Inc. - Chief Strategy Officer

Thank you, operator, and welcome to the Amedisys investor conference call to discuss the results of the second quarter ended June 30, 2022. A copy of our press release, supplemental slides and related Form 8-K filings with the SEC are available on the Investor Relations page of our website. Speaking on today's call from Amedisys will be President and Chief Executive Officer, Chris Gerard; and Executive Vice President and Chief Financial Officer, Scott Ginn. Also joining us is Dave Kemmerly, Chief Legal and Government Affairs Officer.

Before we get started with our call, I would like to remind everyone that statements made on this conference call today may constitute forward-looking statements and are protected under the Safe Harbor of the Private

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot